WEST CONSHOHOCKEN, Pa. (AP) _ Madrigal Pharmaceuticals Inc. (MDGL) on Tuesday reported a loss of $6.5 million in its second quarter.

On a per-share basis, the West Conshohocken, Pennsylvania-based company said it had a loss of 45 cents.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 56 cents per share.

Madrigal shares have more than doubled since the beginning of the year. The stock has risen fifteenfold in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MDGL at https://www.zacks.com/ap/MDGL